Healthcare • Medical Devices
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if XAIR is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
2 top institutions tracked
Sentiment: bullish
Last trade: buy 13 days ago
Red flags: 6
28 filers reported a long position in XAIR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | $207K | 464.2K | Unchanged |
| Murchinson Ltd. | $122.3K | 274.2K | -16.9% |
| Daytona Street Capital LLC | $61.5K | 151.6K | -3.4% |
| GEODE CAPITAL MANAGEMENT, LLC | $50K | 112.2K | -29.6% |
| Bleichroeder LP | $38.6K | 86.5K | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $28K | 62.7K | +96.4% |
| COMMONWEALTH EQUITY SERVICES, LLC | $21.1K | 47.4K | New |
| VANGUARD FIDUCIARY TRUST CO | $13.1K | 29.4K | Unchanged |
| StoneX Group Inc. | $10K | 21.6K | New |
| BlackRock, Inc. | $9.8K | 22K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.